Atlas Trials

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC

Clinical trial NCT07235319 · RECRUITING

Trial details

NCT number
NCT07235319
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharangeal CancerDistant Metastasis
Start date
2025-11-20
Primary completion
2031-11-20
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.